Magnesium carbonate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Deepika Beereddy, MBBS [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Magnesium carbonate is a {{{drugClass}}} that is FDA approved for the treatment of indigestion. Common adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indigestion
- For the temporary relief of upset stomach or sour stomach, and acid indigestion.
- Dosing Information
- The dose of magnesium hydroxide liquid as an antacid is 400 to 1200 milligrams orally up to 4 times daily.
- For the treatment of indigestion, the dose of magnesium oxide tablets is 800 milligrams (482.6 mg elemental magnesium) orally daily with food.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
- There is limited information regarding Off-Label Guideline-Supported Use of Magnesium carbonate in adult patients.
Non–Guideline-Supported Use
- There is limited information regarding Off-Label Non–Guideline-Supported Use of Magnesium carbonate in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
- There is limited information regarding FDA-Labeled Use of Magnesium carbonate in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
- There is limited information regarding Off-Label Guideline-Supported Use of Magnesium carbonate in pediatric patients.
Non–Guideline-Supported Use
- There is limited information regarding Off-Label Non–Guideline-Supported Use of Magnesium carbonate in pediatric patients.
Contraindications
Warnings
- Do not use if you have kidney desease.
- Do not take more than the maximum recommended daily dose (Adults 8 tsps. - children 4 tsps.), or use the maximum dosage of this product for more than 2 weeks, except under the advice and supervision of a doctor.
- May have laxative effect.
- If you are taking prescription drugs. Antacids may interact with certain prescription drugs.
- In the case of accidental overdose, seek professional assistance or contact a Poison Control center immediately.
Adverse Reactions
Clinical Trials Experience
- There is limited information regarding Clinical Trial Experience of Magnesium carbonate in the drug label.
Postmarketing Experience
- There is limited information regarding Postmarketing Experience of Magnesium carbonate in the drug label.
Drug Interactions
There is limited information regarding Magnesium carbonate Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
- There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Magnesium carbonate in women who are pregnant.
Labor and Delivery
- There is no FDA guidance on use of Magnesium carbonate during labor and delivery.
Nursing Mothers
- There is no FDA guidance on the use of Magnesium carbonate with respect to nursing mothers.
Pediatric Use
- There is no FDA guidance on the use of Magnesium carbonate with respect to pediatric patients.
Geriatic Use
- There is no FDA guidance on the use of Magnesium carbonate with respect to geriatric patients.
Gender
- There is no FDA guidance on the use of Magnesium carbonate with respect to specific gender populations.
Race
- There is no FDA guidance on the use of Magnesium carbonate with respect to specific racial populations.
Renal Impairment
- There is no FDA guidance on the use of Magnesium carbonate in patients with renal impairment.
Hepatic Impairment
- There is no FDA guidance on the use of Magnesium carbonate in patients with hepatic impairment.
Females of Reproductive Potential and Males
- There is no FDA guidance on the use of Magnesium carbonate in women of reproductive potentials and males.
Immunocompromised Patients
- There is no FDA guidance one the use of Magnesium carbonate in patients who are immunocompromised.
Administration and Monitoring
Administration
- Intravenous
Monitoring
- There is limited information regarding Monitoring of Magnesium carbonate in the drug label.
- Description
IV Compatibility
- There is limited information regarding IV Compatibility of Magnesium carbonate in the drug label.
Overdosage
- There is limited information regarding Chronic Overdose of Magnesium carbonate in the drug label.
Pharmacology
Mechanism of Action
Structure
There is limited information regarding Magnesium carbonate Structure in the drug label.
Pharmacodynamics
- There is limited information regarding Pharmacodynamics of Magnesium carbonate in the drug label.
Pharmacokinetics
- There is limited information regarding Pharmacokinetics of Magnesium carbonate in the drug label.
Nonclinical Toxicology
- There is limited information regarding Nonclinical Toxicology of Magnesium carbonate in the drug label.
Clinical Studies
- There is limited information regarding Clinical Studies of Magnesium carbonate in the drug label.
How Supplied
There is limited information regarding Magnesium carbonate How Supplied in the drug label.
Storage
There is limited information regarding Magnesium carbonate Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Magnesium carbonate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Magnesium carbonate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
- (Shake well before using)
- Follow dosage below or as directed by a doctor.
- Adults and children 12 yrs. and older: 2 tsps. every 3 to 4 hrs.
- Children 6 to 12 yrs. of age: 1 tsp. every 3 to 4 hrs.
- Children under 2 yrs. of age: consult a doctor before use.
Precautions with Alcohol
- Alcohol-Magnesium carbonate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- ®[1]
Look-Alike Drug Names
- A® — B®[2]
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ Empty citation (help)
- ↑ "http://www.ismp.org". External link in
|title=(help)
{{#subobject:
|Page Name=Magnesium carbonate
|Pill Name=No image.jpg
|Drug Name=
|Pill Ingred=|+sep=;
|Pill Imprint=
|Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
|Pill Color=|+sep=;
|Pill Shape=
|Pill Size (mm)=
|Pill Scoring=
|Pill Image=
|Drug Author=
|NDC=
}}
{{#subobject:
|Label Page=Magnesium carbonate |Label Name=Magnesium carbonate11.png
}}
{{#subobject:
|Label Page=Magnesium carbonate |Label Name=Magnesium carbonate11.png
}}